Correction to: A case of intracoronary and endovenous levosimendan as a rescue therapy for refractory cardiac arrest
After publication of this supplement [1], it was brought to our attention that the author ‘L. Vegnuti’ has been erroneously omitted from the author list of the following abstract.
Main Authors: | B. Ferro, R. Tofani, L. Vegnuti, G. Borelli, L. Gargani, P. Roncucci |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-01-01
|
Series: | Intensive Care Medicine Experimental |
Online Access: | https://doi.org/10.1186/s40635-019-0289-3 |
Similar Items
-
Intracoronary levosimendan during ischemia prevents myocardial apoptosis.
by: Markus eMalmberg, et al.
Published: (2012-02-01) -
ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest
by: Li YT, et al.
Published: (2017-11-01) -
Levosimendan. A promising future drug for refractory cardiac failure in children?
by: Supriya Kushwah, et al.
Published: (2016-04-01) -
Levosimendan combined with epinephrine improves rescue outcomes in a rat model of lipid-based resuscitation from bupivacaine-induced cardiac arrest
by: Fubei Nan, et al.
Published: (2017-09-01) -
Use of Levosimendan in Cardiac Anesthesiology
by: L. A. Krichevsky, et al.
Published: (2011-08-01)